Ann Hutchinson

Biography

 Ann brings a unique blend of marketing, financial, and business development skills applied to the commercialization of life science innovations. For more than 20 years, she has been passionate about bringing vision, clarity and momentum to biopharmaceutical companies’ pipeline opportunities. Before joining Strongbridge in 2015, she led the commercial launch of Daytrana® (methylphenidate) at Shire, the first transdermal medication for the treatment of ADHD. For the next eight years she led a consultancy which focused on expanding her clients’ capacity to pursue new product opportunities, providing strategic marketing insights during design of clinical development programs, and enhancing launch plans to accelerate product trial and adoption. Prior, Ann spent 17 years with Merck, gaining experience with business development, market research, sales, and marketing – including a ten-year emphasis on marketing planning for products in Phase I through launch. Ann received her MBA in finance from Columbia University and a BS in chemical engineering from Penn State.

Research Interest

 Healthcare